Technical Analysis for OPNT - Opiant Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Down |
| Historical OPNT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| 20 DMA Support | Bullish | 3.93% | |
| Hammer Candlestick | Bullish | 3.93% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 3.93% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 3.93% | |
| Wide Bands | Range Expansion | 3.93% | |
| Down 3 Days in a Row | Weakness | 3.93% | |
| MACD Bearish Signal Line Cross | Bearish | -0.74% | |
| Wide Bands | Range Expansion | -0.74% | |
| Narrow Range Bar | Range Contraction | -2.17% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Up 5% | about 13 hours ago | |
| Up 3% | about 14 hours ago | |
| Non-ADX 1,2,3,4 Pullback Entry | about 14 hours ago | |
| 1,2,3, Pullback Entry | about 14 hours ago | |
| Hammer Candlestick Entry | about 14 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/04/2021
Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chloride Opioid FDA Organic Chemistry Xone Nasal Spray Addiction Heroin Cocaine Company's Pipeline Naloxone United States Food And Drug Administration Bulimia Nervosa Eating Disorder
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chloride Opioid FDA Organic Chemistry Xone Nasal Spray Addiction Heroin Cocaine Company's Pipeline Naloxone United States Food And Drug Administration Bulimia Nervosa Eating Disorder
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.9754 |
| 52 Week Low | 6.7878 |
| Average Volume | 79,665 |
| 200-Day Moving Average | 9.20 |
| 50-Day Moving Average | 10.33 |
| 20-Day Moving Average | 12.89 |
| 10-Day Moving Average | 13.86 |
| Average True Range | 0.81 |
| ADX | 59.37 |
| +DI | 27.74 |
| -DI | 17.23 |
| Chandelier Exit (Long, 3 ATRs ) | 12.54 |
| Chandelier Exit (Short, 3 ATRs ) | 11.83 |
| Upper Bollinger Band | 15.51 |
| Lower Bollinger Band | 10.26 |
| Percent B (%b) | 0.62 |
| BandWidth | 40.72 |
| MACD Line | 1.02 |
| MACD Signal Line | 1.17 |
| MACD Histogram | -0.1535 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.51 | ||||
| Resistance 3 (R3) | 14.45 | 14.06 | 14.34 | ||
| Resistance 2 (R2) | 14.06 | 13.80 | 14.09 | 14.29 | |
| Resistance 1 (R1) | 13.78 | 13.64 | 13.92 | 13.84 | 14.23 |
| Pivot Point | 13.39 | 13.39 | 13.46 | 13.42 | 13.39 |
| Support 1 (S1) | 13.11 | 13.13 | 13.25 | 13.16 | 12.77 |
| Support 2 (S2) | 12.71 | 12.97 | 12.74 | 12.71 | |
| Support 3 (S3) | 12.43 | 12.71 | 12.66 | ||
| Support 4 (S4) | 12.49 |
